[Current aspects of glucocorticoid therapy of rheumatic diseases. Pulse-therapy].
Mechanisms of action, clinical efficacy and safety of superhigh doses of methylprednisolone (pulse-therapy) in patients with SLE, RA, systemic vasculitis, Sjogren's disease are outlined.
Solovyev
S K
SK
Ivanova
M M
MM
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000009:adverse effects; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008775:Methylprednisolone / Q000008:administration & dosage* / Q000009:adverse effects; D020551:Pulse Therapy, Drug; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000503:physiopathology
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D008775:Methylprednisolone